This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BAF | Ann: Daily share buy-back notice - Appendix 3E | 28/03/19 | 0 | 52 | |||
|
|||||||
BAF | Ann: Daily share buy-back notice - Appendix 3E | 27/03/19 | 0 | 51 | |||
|
|||||||
BAF | Ann: Daily share buy-back notice - Appendix 3E | 09:05 | 0 | 54 | |||
|
|||||||
BAF | Ann: Daily share buy-back notice - Appendix 3E | 25/03/19 | 0 | 77 | |||
|
|||||||
BAF | Ann: Daily share buy-back notice - Appendix 3E | 21/03/19 | 0 | 60 | |||
|
|||||||
BAF | Ann: Cancellation of shares - Buy-back - ASIC Form 484 | 20/03/19 | 0 | 59 | |||
|
|||||||
BAF | Ann: Daily share buy-back notice - Appendix 3E | 20/03/19 | 0 | 54 | |||
|
|||||||
BAF | Ann: Daily share buy-back notice - Appendix 3E | 19/03/19 | 0 | 971 | |||
|
See All Discussions